Walleye Capital LLC Oncorus, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.44 - $5.62 $21,581 - $84,226	-14,987 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$5.03 - $11.63 $75,384 - $174,298	14,987 New	14,987 $78,000
Q2 2021 Aug 16, 2021	SELL	$13.3 - $17.3 $304,171 - $395,651	-22,870 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$11.89 - $35.55 $271,924 - $813,028	22,870 New	22,870 $318,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.